MedTrace Logo

Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay

NCT02912065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2016-10-05

No results posted yet for this study

Summary

A retrospective chart review to assess feeding tolerance in children who had been switched from an intact protein formula to a Peptide based formula due to feeding intolerance in a pediatric facility for the developmentally delayed.

Conditions

  • Developmental Disabilities
  • Feeding Disorder

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Gerard Minor, PA-C · Childrens Center for Gastroenterology

Eligibility

Min Age
13 Months
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02912065 on ClinicalTrials.gov